H&H INTL HLDG (01112): Total revenue for the first three quarters rose 24.5% year on year on a reported basis.

H&H INTL HLDG (01112) announces that for the nine months ended September 30, 2026, total revenue rose 24.5% year on year on a reported basis (up 24.4% on a like-for-like basis) to RMB13.448 billion, mainly driven by strong growth in the adult nutrition and care products segment and the infant and toddler nutrition and care products segment. In the third quarter, the Group increased investment in the launch of strategic new products and strengthened various initiatives targeting core markets and selected expansion markets to support sustainable growth. High-margin nutritional supplements accounted for 59.5% of revenue, with vitamin, herbal and mineral supplement products, pet nutrition products, and infant probiotics and children's nutritional supplement products achieving growth of 16.6%, 8.1% and 9.4%, respectively, on a like-for-like basis. The adult nutrition and care products segment grew 17.7% year on year (up 16.4% on a like-for-like basis), as the Group continued to achieve comprehensive growth in its core mainland China and ANZ domestic markets as well as expansion markets. The infant and toddler nutrition and care products segment grew 44.6%, driven by 54.5% growth in the mainland China infant formula milk powder business. The Group's market share in mainland China's super-premium infant formula milk powder segment rose from 15.4% last year to 22.3%, a record high. Growth in the pet nutrition and care products segment slowed to 0.2% on a like-for-like basis, mainly due to an expected decline in sales in mainland China. However, high-margin pet nutrition products achieved 8.1% growth. The Group continued to optimize its balance sheet. In the first nine months of 2026, the Group reduced total debt by more than RMB1.3 billion. As of September 30, 2026, RMB-denominated borrowings together with RMB hedging arrangements now provide risk coverage equivalent to 100% of total borrowings.